Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
21 05 2020
Historique:
received: 23 04 2020
revised: 18 05 2020
accepted: 18 05 2020
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 26 2 2021
Statut: epublish

Résumé

Boron neutron capture therapy (BNCT) is a unique anticancer technology that has demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine (BPA) and sodium borocaptate (BSH) used as

Identifiants

pubmed: 32455737
pii: cells9051277
doi: 10.3390/cells9051277
pmc: PMC7290312
pii:
doi:

Substances chimiques

Boron N9E3X5056Q
Mannose PHA4727WTP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Carbohydr Res. 1990 Sep 19;205:385-97
pubmed: 2148907
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):396-403
pubmed: 27084657
BMC Cancer. 2016 Nov 8;16(1):859
pubmed: 27821116
Rep Pract Oncol Radiother. 2016 Mar-Apr;21(2):95-101
pubmed: 26933390
J Hepatol. 2019 Dec;71(6):1206-1215
pubmed: 31499129
Chembiochem. 2002 Mar 1;3(2-3):219-25
pubmed: 11921401
J Control Release. 2014 May 28;182:99-110
pubmed: 24631863
J Cereb Blood Flow Metab. 1997 Feb;17(2):204-9
pubmed: 9040500
Biochem Biophys Res Commun. 1988 Jun 30;153(3):1038-44
pubmed: 3390170
CNS Oncol. 2016;5(2):101-8
pubmed: 26997129
J Biomed Mater Res A. 2014 Dec;102(12):4545-53
pubmed: 24677479
Int J Mol Sci. 2020 Mar 13;21(6):
pubmed: 32183096
Int J Cancer. 1996 Sep 27;68(1):114-9
pubmed: 8895550
Bioorg Khim. 2006 Nov-Dec;32(6):632-42
pubmed: 17180914
Melanoma Res. 1999 Feb;9(1):75-83
pubmed: 10338337
Appl Radiat Isot. 2014 Jun;88:2-11
pubmed: 24355301
Oncotarget. 2016 Oct 4;7(40):65231-65246
pubmed: 27533452
Mass Spectrom (Tokyo). 2018;7(1):A0065
pubmed: 29515945
Future Med Chem. 2013 Apr;5(6):693-704
pubmed: 23617431
Radiat Res. 2001 Apr;155(4):611-8
pubmed: 11260663
Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S25-6
pubmed: 19375927
Biochem Mol Med. 1997 Apr;60(2):127-33
pubmed: 9169093
Int J Biol Markers. 2017 Jul 24;32(3):e278-e283
pubmed: 28085174
Cancer Commun (Lond). 2018 Jun 19;38(1):35
pubmed: 29914561
J Microencapsul. 2017 Sep;34(6):513-521
pubmed: 28705043
Appl Radiat Isot. 2011 Dec;69(12):1796-9
pubmed: 21459588
Beilstein J Org Chem. 2019 Jun 19;15:1355-1359
pubmed: 31293685
Mucosal Immunol. 2016 Jul;9(4):960-73
pubmed: 26530135
Ann Transl Med. 2017 Apr;5(8):183
pubmed: 28616398
Cancer Res. 1992 Jul 15;52(14):3972-9
pubmed: 1617673
Proteomics Clin Appl. 2010 Feb;4(2):143-58
pubmed: 21137040
Oncogene. 2019 Jul;38(28):5599-5611
pubmed: 30967626
Bioorg Med Chem. 2006 Aug 1;14(15):5083-92
pubmed: 16651000
Toxicol Res. 2016 Jul;32(3):177-93
pubmed: 27437085
J Radiat Res. 2018 Mar 1;59(2):101-107
pubmed: 29281044
J Neurooncol. 2003 Mar-Apr;62(1-2):47-59
pubmed: 12749702
Cancer Commun (Lond). 2018 Jun 19;38(1):36
pubmed: 29914575
Beilstein J Org Chem. 2016 Dec 14;12:2748-2756
pubmed: 28144345
Cell Metab. 2015 Jan 6;21(1):65-80
pubmed: 25565206
Chem Rev. 1998 Jun 18;98(4):1515-1562
pubmed: 11848941
Drug Discov Today. 2018 Jan;23(1):63-75
pubmed: 28886331
Bioorg Med Chem. 2018 Dec 1;26(22):5922-5933
pubmed: 30420329
J Med Chem. 1999 Apr 8;42(7):1282-92
pubmed: 10197971
Biochem Biophys Res Commun. 2014 Oct 17;453(2):220-8
pubmed: 24931670
Mol Pharm. 2016 May 2;13(5):1668-78
pubmed: 27010700
J Clin Invest. 1963 Aug;42:1300-12
pubmed: 14057858
Neurol Med Chir (Tokyo). 2016 Jul 15;56(7):361-71
pubmed: 27250576
Eur J Pharm Biopharm. 2013 Aug;84(3):505-16
pubmed: 23376242
IUBMB Life. 2015 Mar;67(3):218-26
pubmed: 25854316
Chem Commun (Camb). 2012 Jan 14;48(4):612-4
pubmed: 22114760
Glia. 1997 Sep;21(1):2-21
pubmed: 9298843

Auteurs

Takao Tsurubuchi (T)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

Makoto Shirakawa (M)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.
Department of Pharmaceutical Sciences, University of Fukuyama, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Hiroshima, Japan.

Wataru Kurosawa (W)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Kayo Matsumoto (K)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Risa Ubagai (R)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Hiroshi Umishio (H)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Yasuyo Suga (Y)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Junko Yamazaki (J)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Akihiro Arakawa (A)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Yutaka Maruyama (Y)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Takuya Seki (T)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Yusuke Shibui (Y)

Institute for Innovation, Ajinomoto Co., Inc., 1-1 Suzukichō, Kawasaki-ku, Kawasaki 210-8681, Kanagawa, Japan.

Fumiyo Yoshida (F)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

Alexander Zaboronok (A)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

Minoru Suzuki (M)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro-Nishi, Kumatori-cho, Sennan-gun 590-0494, Osaka, Japan.

Yoshinori Sakurai (Y)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro-Nishi, Kumatori-cho, Sennan-gun 590-0494, Osaka, Japan.

Hiroki Tanaka (H)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro-Nishi, Kumatori-cho, Sennan-gun 590-0494, Osaka, Japan.

Kei Nakai (K)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.
Department of Radiation Oncology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

Eiichi Ishikawa (E)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

Akira Matsumura (A)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH